InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Galli Stephen J, Director. Officer active across 1 company, notably Atossa Therapeutics, INC.. Aggregated, 2 filings have been published. Activity tracked since 12 May 2026. The latest transaction was disclosed on 12 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
10,000 shares0Common StockSEC:0001193125-26-224133
10,000 shares0Common StockSEC:0001193125-26-224133:0
2 of 2 declarations
About Galli Stephen J
Stephen J. Galli is a Director at Atossa Therapeutics, Inc. He brings his expertise in strategy and governance to the board. Atossa Therapeutics is a company specializing in developing treatments for breast diseases. Mr. Galli plays an active role in strategic direction and oversight of the company's operations.
